Harrow Announces Third Quarter 2026 Financial Results
Third Quarter 2026 and Selected Highlights: Record third quarter revenue of $99.3 million, up 41% sequentially and 39% year over...
Pharmaceutical
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2026
Awarded $15 Million Procurement Contract from Canadian Department of National Defence for Oral TPOXX in October Corporate Update Conference Call Today...
Xenon Reports Q3 2026 Financial Results and Provides Business Update
New Drug Application for azetukalner in focal seizures submitted to U.S. Food & Drug Administration in September 2026Expanding potential opportunity...
POLYRIZON ADOPTS LIMITED DURATION SHAREHOLDER RIGHTS PLAN
TEL AVIV, Israel, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development-stage biotech...
MBX Biosciences Reports Third Quarter 2026 Financial Results and Corporate Highlights
Enrollment in pivotal Phase 3 oPTimize trial of once-weekly canvuparatide underway 12-week MAD (Part C, Cohort 1) data for MBX...
SIGA Announces Retirement of Chief Scientific Officer Dennis Hruby, Ph.D.
Concludes 30-Year Tenure Leading Development of TPOXX®, the First FDA-Approved Antiviral for the Treatment of SmallpoxNEW YORK, Nov. 09, 2026...
IRulya Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
NEW HAVEN, Conn., Nov. 09, 2026 (GLOBE NEWSWIRE) -- IRulya Therapeutics Inc. (Nasdaq: IRLA), a clinical stage biopharmaceutical company focused...
Annexon Reports Third Quarter 2026 Financial Results, Business Updates and Key Anticipated Milestones
Differentiated C1q Platform Advances Two Registrational Programs with Blockbuster Potential, Driving Near-Term Value Catalysts Tanruprubart U.S./EU FORWARD Data in GBS...
ArriVent BioPharma Reports Third Quarter 2026 Financial Results
Continued enrollment in pivotal Phase 3 ALPACCA study in EGFR PACC-mutant NSCLCPresented encouraging Phase 1 data for ARR-217, a CDH17-targeted...
Septerna Highlights Business Progress and Reports Third Quarter 2026 Financial Results
Phase 1 Clinical Trial for PTH1R Agonist SEP-479 Ongoing; SAD / MAD Data Expected in Q1 2027 Plans to Initiate...
Tiziana KOL Call Highlights Consistency Between Positive Phase 2a INFORM-MS Topline Results and Longer-Term Clinical Benefits Observed in Expanded Access Program for Patients with Non-Active Secondary Progressive Multiple Sclerosis Treated with Intranasal Foralumab
BOSTON, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company...
Spectrocell Strengthens Product Discovery and Customer Engagement with Bioz Badges
PALO ALTO, CA / ACCESS Newswire / November 10, 2026 / Bioz, Inc., a scientific intelligence platform that converts publication...
MyoGlow Reviews 2026 – Is My Derma Dream’s At-Home Arm Device Worth It? (Pros & Cons)
MyoGlow Reviews And Complaints: Researching My Derma Dream's 4-In-1 Arm Device, Real Benefits, Safety, And Refund Policy (Consumer Research) MIAMI,...
Northpoint Recovery Announces Acquisition of Brick House Recovery
BOISE, ID / ACCESS Newswire / November 9, 2026 / Northpoint Recovery Treatment Centers today announced its acquisition of Brick...
What Wild Hearts Reveal
Medtronic LINQ™ insertable cardiac monitors track animal heart activity worldwide, revealing insights into stress, survival, and what "normal" means across...
Los Angeles-Based Alaris Becomes First U.S.-Founded Skincare Brand Backed by Bloomage Biotech
LOS ANGELES, Nov. 9, 2026 /PRNewswire/ -- Alaris has secured an investment from Bloomage Biotechnology Corporation (SSE: 688363), a global...
CVS Health Collaborates With Ronald McDonald House To Bring Fall Fun to Families
WOONSOCKET, RI / ACCESS Newswire / November 9, 2026 / The company hosted a Halloween-themed celebration at the New Haven...
Medical Care Technologies Inc. (OTCID:MDCE) Outlines Operating Focus With Growing Software and Subsidiary Revenue Activity Ahead of Q3 Results
AI Software Focus Delivers Paid Work While Infinite Auctions and Real Game Used Build Revenue Ahead of Q3 Results MESA,...
Modular Medical Completes Comprehensive Patient Market Research Study with Thrivable, Reinforcing Strong Interest in Simplified Insulin Delivery
More Than 540 People with Diabetes Participated in a Three-Phase Study of Treatment Burden, Pump Adoption Barriers and Perceptions of...
Aptevo Presents Preclinical Data at SITC 2026 Showing Potential to Overcome Immune Suppression in Solid Tumors
In lab studies, APVO451 and APVO452 helped immune cells kill cancer cells despite conditions that suppress immune activity - offering...